Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soros Private Equity Partners (SPEP) was the private equity investment arm of Soros Fund Management, the family office founded by George Soros. Established in 1988, the firm focused on leveraged buyouts, recapitalizations, and growth capital investments across a diverse range of industries, including healthcare, financial services, and communications. In 2005, the firm's management team spun off from Soros Fund Management to form TowerBrook Capital Partners, an independent investment firm. While not a biotechnology developer itself, the entity was a significant player in healthcare private equity, investing in various healthcare services and insurance providers during its operation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soros Private Equity.